Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Adicet Bio, Inc. before investing.

In this article, we go over a few key elements for understanding Adicet Bio, Inc.’s stock price such as:

• Adicet Bio, Inc.’s current stock price and volume
• Why Adicet Bio, Inc.’s stock price changed recently
• Upgrades and downgrades for ACET from analysts
• ACET’s stock price momentum as measured by its relative strength

About Adicet Bio, Inc. (ACET)

Before we jump into Adicet Bio, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company’s lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin’s lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.

Want to learn more about Adicet Bio, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Adicet Bio, Inc..

Adicet Bio, Inc.’s Stock Price as of Market Close

As of May 12, 2025, 12:30 PM, CST, Adicet Bio, Inc.’s stock price was $0.674.

Adicet Bio, Inc. is up 10.58% from its previous closing price of $0.610.

During the last market session, Adicet Bio, Inc.’s stock traded between $0.650 and $0.740. Currently, there are approximately 91.07 million shares outstanding for Adicet Bio, Inc..

Adicet Bio, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Adicet Bio, Inc. Stock Price History

Adicet Bio, Inc.’s (ACET) price is currently up 1.86% so far this month.

During the month of May, Adicet Bio, Inc.’s stock price has reached a high of $0.740 and a low of $0.472.

Over the last year, Adicet Bio, Inc. has hit prices as high as $1.730 and as low as $0.447. Year to date, Adicet Bio, Inc.’s stock is down 29.9%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Adicet Bio, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of May 09, 2025,, no analysts have changed their rating of Adicet Bio, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Adicet Bio, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Adicet Bio, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Adicet Bio, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Adicet Bio, Inc. (ACET) by visiting AAII Stock Evaluator.

Relative Price Strength of Adicet Bio, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 09, 2025, Adicet Bio, Inc. has a weighted four-quarter relative price strength of -24.90%, which translates to a Momentum Score of 8 and is considered to be Very Weak.

Want to learn more about how Adicet Bio, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Adicet Bio, Inc. Stock Price: Bottom Line

As of May 12, 2025, Adicet Bio, Inc.’s stock price is $0.674, which is up 10.58% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Adicet Bio, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.